{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:58:34Z","timestamp":1790186314866,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007500","name":"Bloomberg Philanthropies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.josat.2022.208944","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T02:43:55Z","timestamp":1673405035000},"page":"208944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Expanding buprenorphine in U.S. jails: One county's response to addressing the fears of diversion"],"prefix":"10.1016","volume":"146","author":[{"given":"Sara","family":"Whaley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachini","family":"Bandara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.josat.2022.208944_bb0005","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1111\/add.15565","article-title":"Methadone and buprenorphine treatment in United States jails and prisons: Lessons from early adopters","volume":"116","author":"Bandara","year":"2021","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.josat.2022.208944_bb0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2018.09.007","article-title":"Understanding the use of diverted buprenorphine","volume":"193","author":"Cicero","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2022.208944_bb0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/08897077.2019.1572052","article-title":"Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?","volume":"40","author":"Doernberg","year":"2019","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2022.208944_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109254","article-title":"Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder","volume":"231","author":"Evans","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2022.208944_bb0025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/10509674.2019.1582573","article-title":"Implementing access to medication assisted treatment in a drug treatment court: Correlates, consequences, and obstacles","volume":"58","author":"Fendrich","year":"2019","journal-title":"Journal of Offender Rehabilitation"},{"issue":"172","key":"10.1016\/j.josat.2022.208944_bb0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2016.11.037","article-title":"A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release","volume":"2017","author":"Gordon","year":"2017","journal-title":"Drug and Alcohol Dependence."},{"issue":"127","key":"10.1016\/j.josat.2022.208944_bb0035","article-title":"Use of non-prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration","volume":"2021","author":"Gryczynski","year":"2021","journal-title":"Journal of Substance Abuse Treatment."},{"key":"10.1016\/j.josat.2022.208944_bb0040","series-title":"Total number of jails and prisons taken from the Prison Policy Initiative","article-title":"Calculated from Jail and prison opioid project (JPOP) on 7\/30\/21","year":"2022"},{"issue":"12","key":"10.1016\/j.josat.2022.208944_bb0045","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1377\/hlthaff.2017.0890","article-title":"Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine","volume":"36","author":"Krawczyk","year":"2017","journal-title":"Health Affairs Web Exclusive"},{"issue":"4","key":"10.1016\/j.josat.2022.208944_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2013-004666","article-title":"Opioid substitution therapy as a strategy to reduce deaths in prison: Retrospective cohort study","volume":"4","author":"Larney","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.josat.2022.208944_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108267","article-title":"Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration","volume":"123","author":"Monico","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.josat.2022.208944_bb0060","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/ADM.0000000000000381","article-title":"Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal","volume":"12","author":"Moore","year":"2018","journal-title":"J Addict Med."},{"key":"10.1016\/j.josat.2022.208944_bb0065","series-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences","year":"2019"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875922000157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875922000157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:49:31Z","timestamp":1757432971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875922000157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":13,"alternative-id":["S2949875922000157"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2022.208944","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding buprenorphine in U.S. jails: One county's response to addressing the fears of diversion","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2022.208944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"208944"}}